EAST EastPharma

Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2018

Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2018

EASTPHARMA LTD.



London, 08 August 2018 - EastPharma (EAST LI)  informs that it will be releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's  financial statements for the related period on 13 August 2018.

A conference call to review the financial performance for the period ended 30 June 2018 will be hosted by the management of EastPharma at 11:00am London time on 14 August 2018 (06:00am New York time / 12:00-noon Zurich time / 01:00pm Istanbul time). The dial-in details are provided below.

Conference call:

Dial-in Number (UK): +44 (0) 2071 928501

Dial-in Number (US): 19177200181

Dial-in Number (Switzerland): 0445806085

Dial-in Number (Germany): 030221533116

Conference ID:  8859999

For further information, please contact:

Investor Relations:

email:

EastPharma Ltd -  a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit .











EN
08/08/2018

Underlying

EASTEastPharma

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EastPharma

 PRESS RELEASE
Free
EAST EASTPHARMA

Statement re Cancellation

Statement re Cancellation EASTPHARMA LTD (“the Company” or “Eastpharma”) EASTPHARMA’S DELISTING OF ITS GDRS Further to the Company's announcement of 2 May 2019, Eastpharma announces that the cancellation of the the standard listing of its Global Depositary Receipts (“GDRs”) on the Official List and the London Stock Exchange ("LSE") and the cancellation of the admission of the GDRs to trading on the main market of the LSE (the "LSE Delisting") is now effective as of 8.00 a.m.(London time) today, 1 August 2019.  As a result of the above, the relationship agreement entered into at the time...

August 1, 2019 1 EN
Farida Salama ... (+3)
  • Farida Salama
  • Mariam Wael
  • Mohamed Hamza
EAST EASTPHARMA
ORWE Oriental Weaver... ... (+3)

Egypt (Pharos): Pharos Investor Conference: Meeting Minutes – Non-Fo...

The Egyptian middle class is c30mn with a household income between EGP7,000-60,000. In this report, we review CIRA, EAST, MTIE and ORWE.

EAST EASTPHARMA
ORWE ORIENTAL WEAVERS CARPET CO
CIRA EY / CIRA.CA CAIRO INVESTMENT & REAL ESTATE DEVELOPMENT
06/24/19 June 24, 2019 9 EN
 PRESS RELEASE
Free
EAST EASTPHARMA

Annual General Meeting of EastPharma Ltd.

Annual General Meeting of EastPharma Ltd. EASTPHARMA LTD. London, 29 May 2019 - EastPharma (EAST LI), today announces that following todays's Annual General Meeting of EastPharma Ltd, the Board of EastPharma Ltd is pleased to announce that the resolutions for ordinary general assembly meeting proposed were duly passed by shareholders and all the information can be reached through EastPharma Ltd - a company active in manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit  Attachment ...

May 29, 2019 1 EN
Mohamed Hamza
  • Mohamed Hamza
EAST EASTPHARMA

Egypt (Pharos): Eastern Tobacco Q3 18/19 – topline weakens sequentia...

EAST 3Q18/19 revenue increased by 4% YoY but fell 9% QoQ. Since the last price hike was implemented in July 2018, we believe the sequential drop in revenues is the result of slow volume growth, possibly due to weak purchasing power, or lower exports as a result of a stronger EGP/USD. The annual increase in revenues was mostly price-driven, where ASP went up by c.15% in July 2018.

05/15/19 May 15, 2019 5 EN
 PRESS RELEASE
Free
EAST EASTPHARMA

Annual General Meeting of EastPharma Ltd.

Annual General Meeting of EastPharma Ltd. EASTPHARMA LTD. London, 02 May 2019 - EastPharma (EAST LI), today announces that the Annual General Meeting is to be held at 10.00 am on 29 May 2019 at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda. The formal notice of the Meeting and agenda for the Meeting are provided below and audited financial statements of the Company for the year ended 31 December 2018 is available for viewing on the company's website . EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in o...

May 2, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch